10.1016/B978-0-12-397156-2.00199-X 21 BasriA
Consulting with a qualified medical professional can be helpful in finding out what is best for your unique needs
100 Years of Living Well 3:30 p.m
Ethics declarations Conflict of interest The authors indicate that there is no conflict of interest
Medications We Offer Depending on medical evaluation and eligibility, treatment options may include: Semaglutide (e.g., Wegovy, Ozempic) Tirzepatide (e.g., Mounjaro, Zepbound) We also offer compounded semaglutide and tirzepatide prepared by licensed 503A compounding pharmacies when appropriate
A 2024 meta-analysis focusing on PCOS patients revealed that GLP-1 receptor agonists significantly lowered fasting insulin levels, improved results on the 2-hour postoral glucose tolerance test, and reduced HOMA-IR, a key marker of insulin resistance